Pharmaceutical Glass Packaging Market Research Report—Global Forecast till 2030

Pharmaceutical Glass Packaging Market Research Report: Information by Product (Vials, Bottles & Jars, Cartridges & Syringes, and Ampoules), Material (Type I, Type II, and Type III), Application (Generic Drugs, Branded Drugs, and Biological Drugs), and Region (North America, Europe, Asia-Pacific, South America, Middle East & Africa) - Forecast Till 2030

ID: MRFR/PNT/3741-CR | August 2021 | Region: Global | 172 Pages         

Pharmaceutical Glass Packaging Market Speak to Analyst Request a Free Sample

Pharmaceutical Glass Packaging Market

Pharmaceutical Glass Packaging Market is expected to grow USD 8.57 Billion at a CAGR of 8.5% during the forecast 2020-2030

Segmentation
By Product Vials Bottles & Jars Cartridges & Syringes Ampoules
Application Generic Drugs Branded Drugs Biological Drugs
Key Players
Companies Profiled   Schott AG (Germany)   Nipro Corporation (Japan)   Piramal Glass(Mumbai)   Sisecam Group   Owens-Illinois Inc.(US)   Gerresheimer AG (Germany)   SGD Pharma (France)   Bormioli Pharma S.p.A (Italy)   Ardagh Group S.A.(Luxembourg)   West Pharmaceutical Services Inc.(US)
Drivers
Market Driving Forces   Easy to clean    Dust resistant    Non-reactive with the fluids stored    High expansion activities by multinationals    Well-established companies
Request a Free Sample

Pharmaceutical Glass Packaging Market Overview


Pharmaceutical Glass Packaging Market is expected to grow USD 8.57 Billion at a CAGR of 8.5% during the forecast period, says market research future (MRFR). The Pharmaceutical Glass Packaging Market growth is rising at an exponential pace. Today, the pharmaceutical industry is booming due to many important clinical drugs and other services. The use of packaging is crucial in this industry to offer protection for medicines. Especially the glass medicines are gaining more traction due to their exceptional benefits. This glass package provides protection and reduces contamination and other damage to the medicines.


Further, this glass packaging helps in the shelf life of the products. In the upcoming years, the demand for pharmaceutical drugs and medicines are high. This will contribute to massive sales of pharmaceutical glass packaging. The Injectable medicines segment of the market is witnessing the highest demands. Also, this glass packaging prevents carbon oxide from entering the package. Medicines can break down due to external factors.


By preventing hydrolysis and oxidization this package gains more popularity among many pharmacies. The rising importance of biotech medicines is driving more demand for the market. Further, strict governmental regulations make the adoption rate higher. The outbreak of covid 19 is a crucial factor that contributes to the growth of this market. Pharmaceutical glass packaging is used in vaccines and other virus treating drugs. All these are factors that will expand market growth. Pharmaceutical and biotechnology companies will now have access to the expertise of both Gerresheimer AG, a world leader in healthcare and beauty and drug delivery systems for pharma, biotech, and cosmetics, and Nelson Labs, a world leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. Gerrensheimer's Gx Biological Solutions and Nelson Labs have teamed up to create a main packaging solution for injectables that drastically decreases both the risk of failure and the time it takes to get to market. Primary packaging systems (vials, syringes, and cartridges) constructed of glass or cyclic olefin polymer (COP) are now available to our customers without compromising the drug's compatibility, stability, or safety.Segmentation:


The growing demand for packaging from the pharmaceutical industry has been influential in fueling the overall growth of the pharmaceutical glass packaging market.The need for extending the shelf life of pharmaceutical products and technological advancements in pharmaceutical packaging will spur market growth. The global market for pharmaceutical glass packaging has been segmented based on product type, material type, application, and region.


Based on product, the global pharmaceutical glass packaging market has been segmented into vials, bottles & jars, cartridges & syringes, and ampoules. The ampoules segment is expected to grow at a faster rate during the forecast period. In 2019, the bottles & jars segment held a share of 30.90% of the global pharmaceutical glass packaging market. It is projected to register a notable CAGR during the projected timeframe.


By material type, the pharmaceutical glass packaging market has been classified into type I, type II, and type III. The type II segment is projected to grow at the fastest rate during the forecast period. In 2019, the type III segment held a 67.49% share of the global pharmaceutical glass packaging market. It is projected to register a significant over the study period.


By application, the pharmaceutical glass packaging market has been segmented into generic drugs, branded drugs, and biological drugs. The generic drugs segment is projected to grow at the fastest rate during the forecast period. In 2019, the generic drugs segment held a 71.41% share of the global pharmaceutical glass packaging market. It is projected to witness a lucrative growth rate over the study period.


Regional Analysis:


By region, the pharmaceutical glass packaging market is segmented into North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.


Global Pharmaceutical Glass Packaging Market, Based on Region, 2019Pharmaceutical Glass Packaging Market, Based on Region, 2019Source: MRFR analysis


North America is one of the prominent regions for the pharmaceutical glass packaging market. The region has witnessed increased investments in R&D and product innovation as far as glass packaging is concerned. Stringent regulations and policies in the US and Canada, increased consumption of drugs, and rapid growth of the pharmaceutical sector are the factors driving the demand for pharmaceutical glass packaging in the region. The US dominated the pharmaceutical glass packaging market in North America.


In the US, the pharmaceutical glass packaging industry is witnessing rapid growth. With the expanding market for drugs, the demand for glass packaging increases continuously in the pharmaceutical industry. Growing healthcare spending isboosting the growth of the pharmaceutical glass packaging market in the country.


The Asia-Pacific pharmaceutical glass packaging market is projected to register a 7.32% CAGR during the forecast period.China, Japan, and India are the key contributors to the regional market. China is the leading country in the region. However, India is witnessing tremendous growth in the pharmaceutical glass packaging market, mainly due to factors such as growing demand for healthcare centers and rising demand for drugs.


Europe was the third-largest region in the pharmaceutical glass packaging market in 2019, accounting for a 22.35% market share.Germany and the UK are the prominent countries in the pharmaceutical glass packaging market in Europe. An increase in healthcare awareness and a rise in demand for medicines and other drugs among consumers are the key factors driving the growth of the pharmaceutical glass packaging market in these countries.


The pharmaceutical glass packaging market in the Middle East & Africa is projected to grow at a notable pace, mainly due to increasing per capita disposable income among individuals, growing healthcare awareness among individuals, and growing consumption of medicines and drugs.The UAE is one of the most prominent countries for the pharmaceutical glass packaging marketin the Middle East.Furthermore, generic drugs comprise nearly 50% of the overall pharmaceutical market in South Africa, leading to an increase in the demand for glass packaging for different types of drugs and medicines in the country.


In Latin America, the pharmaceutical industry is growing at a decent pace, mainly due to an increasing number of people diagnosed with various diseases. Moreover, the consumption of medicinal drugs and the demand for medical and healthcare centers are increasing considerably in Brazil, Argentina, Chile, and Colombia.Bormioli Pharma, a producer of pharmaceutical glass, has finished renovating its Italy furnace that is used only for making type II glass containers. This project, which was finished last month, is only one of numerous industrial investment efforts that the corporation has implemented. The company's moulded glass production capabilities, which have recently been merged with tubular glass capabilities, will be bolstered by the new project. Two German enterprises specializing in pharmaceutical packaging, including tubular glass vials, have been bought by Bormioli Pharma in the past three years (Type I, II, III). As a result, we have a glass production platform that is very adaptable, able to accommodate a wide range of scenarios and technologies.


Synopsis:


The global pharmaceutical glass packaging market has been segmented based on type, material, application, and region.The global market is mainly driven by various factors such as extending the shelf life of products, technical developments in the growth of pharmaceutical glass packaging, and the increasing demand from the pharmaceutical industry.


Market Drivers:


Extending the Shelf Life of Products:




  • Extending the shelf life of products gives the manufacturers more time to transport and sell the products. This reduces inventory shrinkage due to spoilage, which translates to lower operating costs and more goods reaching the consumers. Moreover, a longer shelf life is convenient for customers, which can drive product sales.




  • Technological Developments in Pharmaceutical Glass Packaging




  • Packaging plays a major role in the pharmaceutical industry for extending the shelf life of medical products as well as storing and transporting medicines, specimen samples, and other drugs. There have been continuous technological advancements in manufacturing glass packaging solutions to meet government regulations and standards to meet international safety standards and regulations.




Market Restraints:


The growth of the pharmaceutical glass packaging market is anticipated to be hindered by the growing demand for plastic packaging.


The availability of other alternatives is the key factor that may reduce the demand for glass packaging in the pharmaceutical industry. Plastic is the primary alternative material used for packaging solutions. Currently, plastic bottles & jars are widely preferred for packaging several pharmaceutical products due to factors such as safety and reduced weight.


Glass and plastic are both recyclable. However, the former has its own set of limitations, as it can only be recycled back into glass. Plastic loses its integrity and, as a result, can be recycled to manufacture a wide range of products such as plastic lumber, carpet filling, and foam packaging, among others, thus lowering the demand for glass packaging to a certain extent.


Market Opportunities:


The increasing demand for pharmaceutical glass packaging in emerging economies is expected to present growth opportunities for the players operating in the global pharmaceutical glass packaging market during the forecast period.


In October 2022, DWK Life Sciences, a leading global manufacturer and provider of precision labware and primary packaging solutions for the Life Science Research, Diagnostics, and Pharmaceutical markets, and Stevanato Group S.p.A., a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, jointly announced a non-exclusive agreement for the distribution and sale of their new RTU solution EZ-fill.


Corning Valor Glass, which was approved by the FDA as the primary package for a commercially available drug, the company in October 2019, has made substantial profits by 2022.


Pharmaceutical Glass Packaging Manufacturer:


The success of the market vendors depends on the market conditions, government support, and industry development. Thus, they must focus on improving their products and expanding their regional presence. Schott AG (Germany), Nipro Corporation (Japan), Piramal Glass(Mumbai), Sisecam Group(Tuzla, TR), Owens-Illinois Inc. (US), being the leading players, held a significant share of the global market in 2019.Gerresheimer AG (Germany), SGD Pharma (France), Bormioli Pharma S.p.A (Italy), Ardagh Group S.A.(Luxembourg), West Pharmaceutical Services Inc. (US), and StoelzleOberglasGmbh (Austria) are some of the other prominent players operating in the pharmaceutical glass packaging market.


The leading players, as mentioned above, are dominating the market due to their diverse product offerings, vast industry experience, and wide geographic reach. These players may strengthen their presence worldwide through expansions and acquisitions during the forecast period. With access to better technologies, players can develop unique and innovative products and services, rendering their competitors’ offerings obsolete. The competitive environment in the global market is likely to intensify further due to the increasing number of expansions.


Recent Developments:


May 2021 


Nirpo Corporation is a pharma market that is partnering with AstraZeneca. Both the companies are partnering for the production of vaccines. Also, they are manufacturing many odes of vaccines for Japan. 


March 2021


Stoelze Glass Group is acquiring new companies. It is acquiring the Hocking glass factory. 


February 2022 


Bormioli Pharma is announcing its collaboration with other companies in this market. Enhancing pharmaceutical application and product of glass packaging are benefits of this collaboration. There is high research in the company that raises bottle resistance and the quality of the packaging. Lowering the carbon footprint in the package is the goal of this company. 


Market Segmentation




  • ByProduct–Vials, Bottles & Jars, Cartridges & Syringes, and Ampoules




  • By Material– Type I, Type II, and Type III




  • By Application – Generic Drugs, Branded Drugs, and Biological Drugs





Report Scope:

Report Attribute/Metric Details
  Market Size   2030: USD 8.57 Billion
  CAGR   8.5% CAGR (2022-2030)
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2019 & 2020
  Forecast Units   Value (USD Billion)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Form, End-and Region - Forecast till 2026
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Gerresheimer AG (Germany), Nipro Corporation (Japan), SCHOTT Pharmaceutical Packaging (U.S.), SGD Pharma (France), Shandong Qidu Pharmaceutical Co.,Ltd. (China), Bormioli Rocco SpA (Italy), Ardagh Group S.A. (Luxembourg), West Pharmaceutical Services, Inc. (U.S.), Piramal Glass (India), and Stölzle-Oberglas Gmbh (Austria)
  Key Market Opportunities   High transparency allows easy inspection of its contents
  Key Market Drivers

  • Easy to clean
  • Dust resistant
  • Non-reactive with the fluids stored
  • High expansion activities by multinationals
  • Well-established companies


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The market can attain a growth rate of more than 8.5% in the coming years.

    The global Pharmaceutical Glass Packaging Market is projected to reach USD 8.57 Billion by 2030, given the technological advancements in the field combined with continuous government initiatives among others.

    The significant companies in the worldwide market are Stölzle-Oberglas Gmbh (Austria), Gerresheimer AG (Germany), Ardagh Group S.A. (Luxembourg), Shandong Qidu Pharmaceutical Co.,Ltd. (China), Nipro Corporation (Japan), West Pharmaceutical Services, Inc. (U.S.), Piramal Glass (India), Bormioli Rocco SpA (Italy), SCHOTT Pharmaceutical Packaging (U.S.), SGD Pharma (France), to name a few.

    The top restraining factor in the market is the tough competition given to pharmaceutical glass packaging from the available substitutes.

    One of the chief advantages of glass packaging includes the inert nature of glass that does not react with the contents any time.

    Pharmaceutical Glass Packaging Product Market Segmentation Tab


    Pharmaceutical Glass Packaging Product Outlook (USD Million, 2018-2030)




    • Vials




    • Bottles & jars




    • Cartridges & Syringes




    • Ampoules




    Pharmaceutical Glass Packaging Application Outlook (USD Million, 2018-2030)




    • Generic drugs




    • Branded drugs




    • Biological drugs




    Pharmaceutical Glass Packaging Regional Outlook (USD Million, 2018-2030)




    • North America Outlook (USD Million, 2018-2030)




      • North America Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • North America Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • US Outlook (USD Million, 2018-2030)




      • US Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • US Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • CANADA Outlook (USD Million, 2018-2030)




      • CANADA Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • CANADA Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs








    • Europe Outlook (USD Million, 2018-2030)




      • Europe Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Europe Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Germany Outlook (USD Million, 2018-2030)




      • Germany Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Germany Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • France Outlook (USD Million, 2018-2030)




      • France Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • France Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • UK Outlook (USD Million, 2018-2030)




      • UK Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • UK Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • ITALY Outlook (USD Million, 2018-2030)




      • ITALY Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • ITALY Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs











      • SPAIN Outlook (USD Million, 2018-2030)




      • Spain Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Spain Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Rest OF Europe Outlook (USD Million, 2018-2030)




      • Rest OF Europe Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • REST OF EUROPE Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs







    • Asia-Pacific Outlook (USD Million, 2018-2030)




      • Asia-Pacific Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Asia-Pacific Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • China Outlook (USD Million, 2018-2030)




      • China Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • China Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Japan Outlook (USD Million, 2018-2030)




      • Japan Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Japan Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • India Outlook (USD Million, 2018-2030)




      • India Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • India Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Australia Outlook (USD Million, 2018-2030)




      • Australia Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Australia Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Rest of Asia-Pacific Outlook (USD Million, 2018-2030)




      • Rest of Asia-Pacific Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Rest of Asia-Pacific Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs








    • Rest of the World Outlook (USD Million, 2018-2030)




      • Rest of the World Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Rest of the World Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Middle East Outlook (USD Million, 2018-2030)




      • Middle East Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Middle East Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Africa Outlook (USD Million, 2018-2030)




      • Africa Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Africa Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs






      • Latin America Outlook (USD Million, 2018-2030)




      • Latin America Pharmaceutical Glass Packaging by Product




        • Vials




        • Bottles & jars




        • Cartridges & Syringes




        • Ampoules






      • Latin America Pharmaceutical Glass Packaging by Application




        • Generic drugs




        • Branded drugs




        • Biological drugs